Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will "very likely" be on the U.S. government's 2027 list of ...

Despite their vocal opposition and their ongoing public relations campaign that has attacked this process, all affected U.S. drugmakers decided to engage in the price negotiations. The daunting ...

President Joe Biden’s Inflation Reduction Act allows Medicare to negotiate costly drug prices with pharmaceutical companies.

The ability to negotiate drug prices is part of a sweeping set of policies in President Joe Biden’s Inflation Reduction Act.

Gov. Tim Walz and Sen. Amy Klobuchar speak at a press conference earlier this summer. Klobuchar says Medicare drug prices ...

the Centers for Medicare and Medicaid Services have the ability to negotiate directly with pharmaceutical companies for the price of medications — and impose punitive taxes if the drugmakers ...

Drugmakers are lowering prices of 10 of the costliest drugs under Medicare, the agency announced last week. The changes are part of the government’s first-ever negotiations aimed at lowering the ...

But drugmakers are often able to extend U.S ... Each year, more drugs will be up for price negotiation by Medicare, which accounts for about a third of U.S. drug spending. "We're going to see ...

Medicare and drugmakers have completed negotiations to cut drug prices for 10 of Medicare's most common and most expensive drugs starting in 2026. Some medications help manage diabetes ...

Despite Medicare's first-ever negotiated drug prices under the Inflation Reduction Act, U.S. costs remain significantly ...